India is deeply committed to achieving all public health goals, says Union Health Min

Highlighting the importance of transparency between regulatory authorities and pharma sector, Nadda stated that the coordination between the National Regulatory Authorities and pharmaceutical sector will enable launch and registration of new health technologies

India is deeply committed to achieving all public health goals, says Union Health Min

The Union Minister of Health and Family Welfare, J P Nadda today inaugurated  the ‘1st World Conference on Access to Medical Products and International Laws for Trade and Health in the Context of the 2030 Agenda for Sustainable Development.’

The Health Minister further stated that there is a need for promoting industry and academia collaboration for developing affordable medical products such that innovations and advances in medical sector reach a vast population.

“India is deeply committed nationally and globally to achieving all public health goals and also focusing on developing India as a hub for affordable medical devices.”

Anupriya Patel, Minister of State (HFW), Dr V.K. Paul, Member, NITI Aayog, Govt. of India, Dr Soumya Swaminathan, Secretary, Dept. of Health & Research (DHR) and DG, ICMR also graced the occasion.

Highlighting the importance of transparency between regulatory authorities and pharma sector, Nadda stated that the coordination between the National Regulatory Authorities and pharmaceutical sector will enable launch and registration of new health technologies.

He further said that the dialogue on role of competition in competitive pricing and discussion on related WTO agreements influencing health should lead to a larger umbrella of suggested policy options for the government.

He stated that the 2015 National Medical Device Policy will enable local  manufacture in the multiproduct, multidisciplinary industry. “In India, nearly 150 thousand orthopaedic knee procedures are done every day. More investments and more players in the medical devices sector will lead to lowering down of prices and access to medical products as most of the governments are sensitive to access and pricing of medical products,” he added.

Dr Soumya Swaminathan, Secretary (DHR) and DG, ICMR highlighted issues such as how to use TRIPs flexibilities; alternative models for affordable medicines and devices such as voluntary licensing; clear predictable regulatory pathways; more investment in R&D and publicly funded R&D

And the need of innovative healthcare service delivery models, antibiotic stewardship and collaboration between the public and private sectors including academia to reduce cost of production and delivery.

Speaking at the function, Anupriya Patel, Minister of State (HFW), stated that India is committed to attainment of the highest possible standards of health for its citizens.

She further said that at the national level, access to medical products (medicines, vaccines, medical devices & diagnostics) is an important facet in the health system as a whole and at the international level, access to medical products is a critical factor for the success of the 2030 sustainable development goals agenda that aims to ensure healthy lives and to promote well-being of people of all ages.

The conference is being organised by the Ministry of Health & Family Welfare with the support of WHO Country Office for India and in partnership with Indian Society of International Law.

The objective of the conference is to exchange knowledge and expand understanding on contemporary issues in international trade laws and research and innovation for access to medical products to achieve SDG 2030 agenda.